Skip to main content
Signal8

HENSON HEIDI

SEC insider (Form 3/4/5 filer). CIK 0001283301. Director at Korsana Biosciences, Inc. (KRSA) and 3 other issuers. 7 reported Form 4/5 transactions since Sep 2024; latest on Jun 18, 2026. Located in WALTHAM, MA.

Companies HENSON HEIDI has filed insider reports for

  • Korsana Biosciences, Inc. (KRSA): Director
  • PepGen Inc. (PEPG): Director
  • Perspective Therapeutics, Inc. (CATX): Director
  • LISATA THERAPEUTICS, INC. (LSTA): Director
HENSON HEIDI profile photo

HENSON HEIDI

CIK: 0001283301

Transaction Breakdown

Open Market Buys (P)1 (14.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (85.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (4)

Korsana Biosciences, Inc. logo
KRSA

Korsana Biosciences, Inc.

Director
PepGen Inc. logo
PEPG

PepGen Inc.

Director
Perspective Therapeutics, Inc. logo
CATX

Perspective Therapeutics, Inc.

Director
LISATA THERAPEUTICS, INC. logo
LSTA

LISATA THERAPEUTICS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • PepGen Inc. logo
    PEPG

    PepGen Inc.

    Jun 18, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    34K shares-
  • Perspective Therapeutics, Inc. logo
    CATX

    Perspective Therapeutics, Inc.

    Mar 2, 2026
    Award

    Stock option (right to buy)

    Direct
    50K shares-
  • LISATA THERAPEUTICS, INC. logo
    LSTA

    LISATA THERAPEUTICS, INC.

    Jan 9, 2026
    Award
    Direct
    30.5K shares-
  • PepGen Inc. logo
    PEPG

    PepGen Inc.

    Jun 4, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    16K shares-
  • Perspective Therapeutics, Inc. logo
    CATX

    Perspective Therapeutics, Inc.

    Mar 3, 2025
    Award

    Stock option (right to buy)

    Direct
    50K shares-
  • LISATA THERAPEUTICS, INC. logo
    LSTA

    LISATA THERAPEUTICS, INC.

    Jan 9, 2025
    Award
    Direct
    15.8K shares-
  • Perspective Therapeutics, Inc. logo
    CATX

    Perspective Therapeutics, Inc.

    Dec 4, 2024
    Purchase
    Indirect
    26K shares at avg. $3.85$100K

1-7 of 7